Insider · CIK 0001773151
Nadia Dac
Files at KYTX (Kyverna Therapeutics, Inc.). First filing -, latest -.
In brief
Nadia Dac files SEC Form 4 as officer at KYTX (Kyverna Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Nadia Dac has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 4, 2026 | KYTX Kyverna Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +300,000 | $0.00 | $0 | 300,000 | May 6, 2026 |
Questions about Nadia Dac
Answered from the filings on this page, as of the latest one.
Is Nadia Dac buying or selling?
Nadia Dac has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Nadia Dac's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Nadia Dac has 0.
Where does Nadia Dac file Form 4?
Nadia Dac has filed Form 4 at KYTX (Kyverna Therapeutics, Inc.) as Chief Commercial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.